Publications by authors named "Yoo Jane Han"

Claim this Profile
F
FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer.
Junyao Zhu, Xinyi Dai, Santanu Ghosh, Elaine Wei, Chengjian Mao, Yoo Jane Han

J Exp Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer.
Yoo Jane Han, Siyao Liu, Ashley Hardeman, Padma Sheila Rajagopal, Jeffrey Mueller

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer.
Yoo Jane Han, Jing Zhang, Ashley Hardeman, Margaret Liu, Olga Karginova

Hum Mol Genet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.
Ashley A Hardeman, Yoo Jane Han, Tatyana A Grushko, Jeffrey Mueller, Maria J Gomez

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pseudogene Negatively Regulates Antitumor Responses through Inhibition of Innate Immune Defense Mechanisms.
Yoo Jane Han, Jing Zhang, Jung-Hyun Lee, Jennifer M Mason, Olga Karginova

Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications.
Yoo Jane Han, Sonja M Boatman, Jing Zhang, Xinxin C Du, Albert C Yeh

Sci Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis